Dependal M - Tablet, Glaxo Smithkline Pharmaceuticals Ltd.

Bacillary dysentery, Cholera, Diarrhoea caused by e-coli, Diarrhoea caused by salmonella species, Diarrhoea caused by shigella species, Giardiasis, Intestinal infection caused by giardia lambia, Travelers diarrhoea, Typhoid.

Amoebiasis, giardiasis, trichomonas vaginitis, anaerobic infections, ulcerative gingivitis. Eradication of H.pylori associated with peptic ulcer disease.
Antibiotic-associated coulitis. Trichomoniasis, Balantidiasis, Blastocyatis hominis infection. Adjunct to treatment of chronic periodontal infections. Rosacea."

Intolerance to alcohol. Hypersensitivity, Below the age of one month.

Alcohol dependence, Blood dyscrasias, Neurosis, Seizures, Hypersensitivity, Liver damage. Pregnancy and lactation.

Nausea, vomiting, dizziness, drowsiness, headache, uneasiness, rash, fever, joint pain, brown urine and anemia.

Encephalopathy, Ataxia, Peripheral neuropathy, Neutropenia, Seizures, Headache, Disorientation, Weakness, Dizziness, Vertigo, Headache, Anorexia, Diarrhea, Palpitation, Insomnia, Dry mouth, Maculopapular rash, Rashes, Stomatitis, Urticaria, Pruritus, Dysuria, GI upset, Flushing, Phlebitis, Nausea and vomiting, Gynecomastia, Chest pain, Metallic taste, Paresthesias, Acute pancreatitis, Darkening of urine, Thrush.

Pregnancy, lactation, G6PD deficiency.

Patients with CNS diseases, discontinue IV therapy if abnormal neurologic symptoms occur. History of seizure disorder. Evidence or a history of blood dyscrasias, perform total and differential leukocyte counts before and after treatment. Severe hepatic impairment, monitor plasma levels. Predisposition to oedema (inj contains sodium). Prolonged use may result in fungal or bacterial superinfection.